The need for economic evaluation in osteoarthritis

Mark Prashker, Jennifer Anderson, Janet E Pope, The efficacy and cost effectiveness of N of 1 studies with diclofenac compared to standard treatment with nonsteroidal antiinflammatory drugs in osteoarthritis. The Journal of Rheumatology. ,vol. 31, pp. 140- 149 ,(2004)

Dan Pericak, David Feeny, Paul Grootendorst, George W Torrance, Deborah Marshall, Nicholas Bellamy, A model to estimate health utilities index mark 3 utility scores from WOMAC index scores in patients with osteoarthritis of the knee. The Journal of Rheumatology. ,vol. 34, pp. 534- 542 ,(2007)

Hirsch S Ruchlin, Ralph P Insinga, A review of health-utility data for osteoarthritis: implications for clinical trial-based evaluation. PharmacoEconomics. ,vol. 26, pp. 925- 935 ,(2008) , 10.2165/00019053-200826110-00005

Jean-Yves Reginster, Christelle Manette, Véronique Rabenda, Anne-Marie Mariani, Nicole Struvay, Régine Lemmens, Direct and indirect costs attributable to osteoarthritis in active subjects. The Journal of Rheumatology. ,vol. 33, pp. 1152- 1158 ,(2006)

A. Laupacis, D. Feeny, P. X. Tugwell, A. S. Detsky, How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations Canadian Medical Association Journal. ,vol. 146, pp. 473- 481 ,(1992)

Lyn March, Helen Lapsley, Kristy Sanderson, Gavin Andrews, Leonardo Simonella, Evidence-based medicine is affordable: the cost-effectiveness of current compared with optimal treatment in rheumatoid and osteoarthritis. The Journal of Rheumatology. ,vol. 33, pp. 671- 680 ,(2006)

John K. Marshall, James M. Pellissier, Cheryl L. Attard, Sheldon X. Kong, Michael A. Marentette, Incremental cost-effectiveness analysis comparing rofecoxib with nonselective NSAIDs in osteoarthritis: Ontario Ministry of Health perspective. PharmacoEconomics. ,vol. 19, pp. 1039- 1049 ,(2001) , 10.2165/00019053-200119100-00005

Michael Loyd, Dale Rublee, Philip Jacobs, An economic model of long-term use of celecoxib in patients with osteoarthritis BMC Gastroenterology. ,vol. 7, pp. 25- 25 ,(2007) , 10.1186/1471-230X-7-25

Véronique Rabenda, Christelle Manette, Régine Lemmens, Anne-Marie Mariani, Nicole Struvay, Jean-Yves Reginster, Prevalence and impact of osteoarthritis and osteoporosis on health-related quality of life among active subjects Aging Clinical and Experimental Research. ,vol. 19, pp. 55- 60 ,(2007) , 10.1007/BF03325211

Katherine Gooch, Peter Faris, Cy Frank, Nicholas Bellamy, George Torrance, David Feeny, Deborah Marshall, Dan Pericak, Paul Grootendorst, Validation of a Prediction Model to Estimate Health Utilities Index Mark 3 Utility Scores from WOMAC Index Scores in Patients with Osteoarthritis of the Hip Value in Health. ,vol. 11, pp. 470- 477 ,(2008) , 10.1111/J.1524-4733.2007.00258.X